regeneron glp-1 Regeneron's COURAGE trial shows semaglutide and trevogrumab combo preserves lean mass | Charles M. Alexander posted on the topic regeneron pharmaceuticals semaglutide The investigational
Description
Irannejad, R
These localized reactions may include redness, itching, swelling, bruising, or discomfort at the injection site
the clinician makes the clinical call
If planning surgery or facing prolonged immobility, discuss with your doctor whether temporary medication adjustments or thromboprophylaxis measures are appropriate, as these situations increase clotting risk independently of GLP-1 therapy
2013, 2014, Ferdinand et al
